Safety of everolimus for women over 65 years of age with advanced breast cancer (BC): 12.5-mo follow-up of BOLERO-2. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pritchard, Kathleen
  • Burris, Howard A
  • Rugo, Hope S
  • Gnant, Michael
  • Baselga, Jose
  • Piccart-Gebhart, Martine J
  • Noguchi, Shinzaburo
  • Dakhil, Shaker R
  • Srimuninnimit, Vichien
  • Puttawibul, Puttisak
  • Osborne, Karen
  • Mukhopadhyay, Pabak
  • Taran, Tanya
  • Sahmoud, Tarek
  • Campone, Mario
  • Hortobagyi, Gabriel N

publication date

  • May 20, 2012